List of Abraxis BioScience patents

Patents where

Current Assignee

Name

Abraxis BioScience

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8137684 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof	Patent 8137684 was granted and assigned to Abraxis BioScience on March, 2012 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	8137684	March 20, 2012
‌ US Patent 11944708 Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin	Patent 11944708 was granted and assigned to Abraxis BioScience on April, 2024 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	11944708	April 2, 2024
‌ US Patent 12061183 Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug	Patent 12061183 was granted and assigned to Abraxis BioScience on August, 2024 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	12061183	August 13, 2024
‌ US Patent 12133844 Methods of treating epithelioid cell tumors	Patent 12133844 was granted and assigned to Abraxis BioScience on November, 2024 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	12133844	November 5, 2024
‌ US Patent 7820788 Compositions and methods of delivery of pharmacological agents	Patent 7820788 was granted and assigned to Abraxis BioScience on October, 2010 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7820788	October 26, 2010
‌ US Patent 7923536 Compositions and methods of delivery of pharmacological agents	Patent 7923536 was granted and assigned to Abraxis BioScience on April, 2011 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7923536	April 12, 2011
‌ US Patent 8999396 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane	Patent 8999396 was granted and assigned to Abraxis BioScience on April, 2015 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	8999396	April 7, 2015
‌ US Patent 7771751 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents	Patent 7771751 was granted and assigned to Abraxis BioScience on August, 2010 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7771751	August 10, 2010
‌ US Patent 9012518 Compositions and methods of delivery of pharmacological agents	Patent 9012518 was granted and assigned to Abraxis BioScience on April, 2015 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9012518	April 21, 2015
‌ US Patent 9012519 Compositions and methods of delivery of pharmacological agents	Patent 9012519 was granted and assigned to Abraxis BioScience on April, 2015 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9012519	April 21, 2015
‌ US Patent 7758891 Combinations and modes of administration of therapeutic agents and combination therapy	Patent 7758891 was granted and assigned to Abraxis BioScience on July, 2010 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7758891	July 20, 2010
‌ US Patent 8138229 Compositions and methods of delivery of pharmacological agents	Patent 8138229 was granted and assigned to Abraxis BioScience on March, 2012 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	8138229	March 20, 2012
‌ US Patent 9724323 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane	Patent 9724323 was granted and assigned to Abraxis BioScience on August, 2017 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9724323	August 8, 2017
‌ US Patent 9675578 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane	Patent 9675578 was granted and assigned to Abraxis BioScience on June, 2017 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	9675578	June 13, 2017
‌ US Patent 8034375 Combinations and modes of administration of therapeutic agents and combination therapy	Patent 8034375 was granted and assigned to Abraxis BioScience on October, 2011 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	8034375	October 11, 2011
‌ US Patent 9399072 Methods of treatment of pancreatic cancer	Patent 9399072 was granted and assigned to Abraxis BioScience on July, 2016 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9399072	July 26, 2016
‌ US Patent 8735394 Combinations and modes of administration of therapeutic agents and combination therapy	Patent 8735394 was granted and assigned to Abraxis BioScience on May, 2014 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	8735394	May 27, 2014
‌ US Patent 9820949 Methods of treatment of pancreatic cancer	Patent 9820949 was granted and assigned to Abraxis BioScience on November, 2017 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9820949	November 21, 2017
‌ US Patent 7780984 Methods and compositions for treating proliferative diseases	Patent 7780984 was granted and assigned to Abraxis BioScience on August, 2010 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7780984	August 24, 2010
‌ US Patent 9399071 Methods of treatment of pancreatic cancer	Patent 9399071 was granted and assigned to Abraxis BioScience on July, 2016 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	9399071	July 26, 2016
‌ US Patent 9561288 Combinations and modes of administration of therapeutic agents and combination therapy	Patent 9561288 was granted and assigned to Abraxis BioScience on February, 2017 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9561288	February 7, 2017
‌ US Patent 9101543 Combinations and modes of administration of therapeutic agents and combination therapy	Patent 9101543 was granted and assigned to Abraxis BioScience on August, 2015 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	9101543	August 11, 2015
‌ US Patent 9597409 Methods of treating cancer	Patent 9597409 was granted and assigned to Abraxis BioScience on March, 2017 by the United States Patent and Trademark Office.	Abraxis BioScience	Abraxis BioScience	United States Patent and Trademark Office	9597409	March 21, 2017
‌ US Patent 8257733 Methods and compositions for treating proliferative diseases	Patent 8257733 was granted and assigned to Abraxis BioScience on September, 2012 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	8257733	September 4, 2012
‌ US Patent 7981445 Compositions and methods for preparation of poorly water soluble drugs with increased stability	Patent 7981445 was granted and assigned to Abraxis BioScience on July, 2011 by the United States Patent and Trademark Office.		Abraxis BioScience	United States Patent and Trademark Office	7981445	July 19, 2011

Results per page:

62 results

0 selected

62 results

0 selected